Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merz North America, Inc.
For all subjects, standardized photographs of the lips will be taken at the screening visit (prior to treatment) and at multiple intervals throughout the study to be used for comparisons and study assessments.
Subjects will receive an injection of either BIL or Restylane Silk (RS) in the upper and/or lower lips. A touch-up injection will be given 4 weeks after the initial treatment if the subject fails to show improvement in 1 or both lips or if the subject does not achieve optimal aesthetic correction. Subjects treated with BIL have the option of a retreatment with BIL 48 weeks post last injection.
Age
21–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Desires lip augmentation to correct volume and has very thin to medium upper and/or lower lip deficit
You may not be if
Any previous surgery, including plastic surgery or permanent implant or graft in the lower third part of the face
Any previous treatment with fat injections or permanent and/or semi-permanent dermal fillers in the face
Any treatment with porcine-based collagen fillers or with Juvéderm® Voluma XC, Restylane® Lyft Lidocaine, Calcium hydroxyapatite (CaHA) within the past 24 months and/or other dermal fillers within the past 12 months in the lips, in the lower third part of the face, and/or the nose
Any previous treatment with dermal therapies within the past 3 months in the lower third part of the face
Has undergone oral surgery in the past 30 days
Lip volume deficit due to medical conditions
Known history of allergic/anaphylactic reactions/hypersensitivity to lidocaine or any of the device components
Clareo Health | A Study of Belotero® Intense Lidocaine for Lip Augmentation
